USEL Stock News 4.3700 05/06/2014 13:17:07 Usell.Com Inc. (U

New Post Public Reply Private Reply Replies (0) Message Board
Stock_Tracker
Usell.Com Inc. (USEL) 4.3700 $USEL

uSell.com Reports 2013 Annual Results
eTeligis - Tue Apr 01, 7:01AM CDT
uSell.com (OTCQB:USEL), the leading US-based reCommerce marketplace that instantly finds cash offers for used smartphones and electronics, announced today record results for the fourth quarter and year ended December 31, 2013.

RedChip TV Announces Lineup for This Week's Show on Bloomberg
GlobeNewswire - Wed Mar 12, 1:43PM CDT
RedChip Companies, Inc. ("RedChip", an international small-cap research, investor relations, and media company, today announced that "The RedChip Money Report: Small Stocks Big Money" (TM) television program will feature two emerging growth companies on Bloomberg U.K. Saturday, March 15, 2014 at 12:30 a.m. GMT; on Bloomberg Europe Sunday, March 16, 2014 at 8:30 a.m.; and on Bloomberg Asia on Sunday March 16, 2014 at 3:30 p.m. HKT. The show will also air on Fox Business nationwide on Thursday, March 13, 2014 at 10:00 p.m. Pacific (1 a.m. EDT).

uSell.com to Present at the 10th Annual Noble Financial Capital Markets Conference
Marketwire - Mon Jan 13, 7:00AM CST
uSell.com, Inc. (OTCQB: USEL), the first US-based reCommerce marketplace that instantly finds cash offers for used smartphones and electronics, announced today that Daniel Brauser, Chief Executive Officer, and Nik Raman, Chief Operating Officer, will present at "TEN" Noble Financial Capital Markets' 10th Annual Equity Conference, on January 21, 2014 at 2:30pm EST. The conference will be held January 19-22, 2014 at Club Med, Sandpiper Bay, South Florida. CEO Daniel Brauser will be available during the conference for one-on-one meetings. To schedule a meeting, please contact your Noble Financial representative or the contact mentioned below.

uSell.com Announces Record Quarterly Results
PR Newswire - Wed Nov 20, 7:00AM CST
Third Quarter Revenues reach $1.6 Million, an Increase of 124 Percent

uSell.com Announces New Resale Product Categories
PR Newswire - Tue Jun 25, 8:00AM CDT
uSell.com (OTCBB: USEL), the first US-based reCommerce marketplace that instantly finds cash offers for used smartphones and electronics, has announced its expansion into women's and children's apparel, textbooks, video games and gift cards.

uSell.com to Present at the First Annual Singular Research Solstice Conference
PR Newswire - Wed Jun 12, 7:00AM CDT
uSell.com, Inc. (OTCBB: USEL), a leading reCommerce platform that helps users turn unused items into cash, announced today that it has been invited to present at the First Annual Singular Research Solstice Conference at the Millenium Broadway Hotel in New York City on Thursday, June 13, 2013 at 1:45pm EDT. Sergio Zyman, Chairman and CEO, and Nik Raman, COO, will be available during the day for one-on-one meetings. To schedule a meeting, please contact your Singular Research representative or the contact who is mentioned below.
Scroll down for more posts ▼

Top 10 Most Recent News Articles

Terminus Ballet: A Decade of Defying Dance Norms

Updated Category News Views 135

A Dance Company's Journey of Transformation An anniversary represents more than just a celebration; it's a reminder of the road traveled. On Jan. 30, 2027, Terminus Modern Ballet Theatre will mark its 10th anniversary, encapsulating a decade of defiance against the staid conventions binding classical ballet. This isn't just about pirouettes and pliés—it's dance with a...

Continue Reading
Bacterial Breakthrough in Cancer Therapy: Game Changer?

Updated Category News Views 35

Blurring Lines Between Bugs and Biotech Well, wouldn't you know it, the eggheads over at Jeonbuk National University in South Korea are at it again, pushing the boundaries of what these little bacterial buggers can do. This time, they’ve had a crack at cancer therapy, using engineered Salmonella to pack a double punch against breast cancer in mice. Now, if that ain't...

Continue Reading
Lennar Faces Securities Fraud Lawsuit: Investor Insights

Updated Category News Views 20

Investors in Lennar: Navigating the Legal Storm Hold onto your hats, folks. Lennar Corporation (NYSE: LEN) is up against it with a brand-spanking-new securities fraud lawsuit helmed by Schall, Brown & Schwartz LLP (SBS). This isn't just a couple of investors grumbling over cocktails; it’s a full-blown class action that’s waving the legal banner under the Securities...

Continue Reading
Nauticus Robotics Dive into Defense & UAE Moves

Updated Category News Views 78

Charting New Waters: Defense and UAE Focus Looking at Nauticus Robotics lately, it feels like they're finally getting the hang of balancing their defense play and UAE expansions. This quarter they're coming out swinging, dropping some fine numbers mixed with a slew of strategic moves that got me thinking twice about their place in the subsea robotics world. Financial...

Continue Reading
Tenax Therapeutics Facing Class Action: DEC 28 Deadline

Updated Category News Views 70

Legal Storm Over Tenax Therapeutics Just what the doctor didn't order—legal headaches for Tenax Therapeutics, Inc. (NASDAQ:TENX). Yup, folks, buckle up because we're diving into another class action mudslinging match that’s setting the markets wagging. Berger Montague's law trebuchet is aimed squarely at Tenax and every investor should know the target’s outline....

Continue Reading
Graphic Packaging Shakes Up Leadership and Supply Chain

Updated Category News Views 29

New Leadership Takes the Helm at Graphic Packaging What do you do when you want to streamline an operation that spans continents? Well, if you're Graphic Packaging Holding Company (NYSE: GPK), you bring in fresh leadership to serenade the chaos into a well-oiled machine. Starting December 1, 2026, D. Keith Hamilton will be sinking his teeth into North America Mills &...

Continue Reading
Akeso's Gumokimab Wins NMPA Approval for AS Treatment

Updated Category News Views 194

Gumokimab Approved: A New Dawn in AS Treatment Yeah, the biotech world shifts gears today as Akeso's gumokimab received the green light from China's National Medical Products Administration (NMPA). This approval for treating ankylosing spondylitis, or AS, isn't just another checkbox for Akeso; it's a game-changer in tackling this chronic inflammatory disease. Why should...

Continue Reading
Sasol AGM Resolutions Passed in One Swift Swing

Updated Category News Views 119

Sasol's AGM Delivers Smooth Sailing for Shareholders Can't say I'm surprised, but Sasol's annual general meeting on the 13th of November went off without a hitch—unless, of course, you're one of those folks who just loves fireworks at these gatherings. The entire set of resolutions danced through with a resounding "Aye," making it one heck of a day for anyone banking on...

Continue Reading
ROBOTERA Debuts XHAND 1 Pro-U in NVIDIA Demo

Updated Category News Views 117

ROBOTERA Steps Up with XHAND 1 Pro-U Move over, traditional robotics; ROBOTERA is here to shake things up with their latest marvel, the XHAND 1 Pro-U. This futuristic gadget isn't just making waves at the Conference on Robot Learning (CoRL) where Jim Fan of NVIDIA spotlighted it in his GR00T 2 demo, it's setting a new bar for robotic dexterity. Hand in Glove with Human...

Continue Reading
Saint Luis Rey Launches Exclusive Palatinos Vitola

Updated Category News Views 59

New Beginnings for the Saint Luis Rey Brand You think you've seen it all in the cigar world, but then comes a debut like this that lights a fire under the lush tradition of Cuba. Enter Saint Luis Rey's new Palatinos vitola, a blend wrapped in the mystique of exclusivity for La Casa del Habano and Habanos Specialists. Whether you're a seasoned connoisseur or just dipping...

Continue Reading

Top 5 Most Recently Viewed Articles

Ocuphire Pharma Faces Scrutiny Over Shareholder Obligations

Updated Category News Views 81

Ocuphire Pharma Under Investigation by Ademi LLP Recently, there have been growing concerns regarding the fiduciary responsibilities of Ocuphire Pharma, Inc. (NASDAQ: OCUP) to its public shareholders. Ademi LLP has initiated an investigation focused on whether the company is adequately protecting the interests of its shareholders amidst its dealings with Opus Genetics....

Continue Reading
Investigation Into Shareholder Claims Against AMLX, FIVE, HUM, and VSTS

Updated Category News Views 190

Grabar Law Office Investigates Shareholders' Rights Amylyx Pharmaceuticals, Inc. (NASDAQ: AMLX), Five Below, Inc. (NASDAQ: FIVE), Humana Inc. (NYSE: HUM), and Vestis Corp. (NYSE: VSTS) shareholders may have claims worth exploring. Grabar Law Office wants to inform these shareholders about the ongoing investigations into potential securities fraud that could have affected...

Continue Reading
Investors Seek Recovery in Class Action Against Paragon 28, Inc.

Updated Category News Views 109

Class Action Lawsuit Filed for Paragon 28, Inc. Investors We are reaching out to inform investors about an important class action securities lawsuit involving Paragon 28, Inc. This initiative aims to recover losses for investors who may have been adversely affected by purported securities fraud associated with the company. Details of the Class Action The class action...

Continue Reading
Alto Ingredients, Inc. Announcement for Q2 2025 Results

Updated Category News Views 165

Alto Ingredients, Inc. to Announce Second Quarter Financial Results Alto Ingredients, Inc. (NASDAQ: ALTO), a prominent producer and distributor of specialty alcohols and renewable fuels, is set to release its financial results for the second quarter of 2025. This announcement will take place after the market closes on Wednesday, August 6, 2025. Conference Call Details...

Continue Reading
Phare Bio Secures $27 Million to Revolutionize Antibiotic Discovery

Updated Category News Views 226

Phare Bio scored big back in 2024 with up to $27 million in funding from the Advanced Research Projects Agency for Health (ARPA-H). This isn’t just pocket change; it’s a lifeline aimed at supercharging their generative artificial intelligence (AI) platform. Teaming up with MIT's Collins Lab and Harvard's Wyss Institute, they set their sights on developing new classes...

Continue Reading